In Vivo Purging with Rituximab Before Stem Cell Collection and Maintenance Rituximab After Transplant for Patients with Relapsed Follicular Lymphoma (FL)
In Vivo Purging with Rituximab Before Stem Cell Collection and Maintenance Rituximab After Transplant for Patients with Relapsed Follicular Lymphoma (FL)
Slides from a presentation at ASCO 2010 and transcribed comments from recent interviews with Stephanie A Gregory, MD (6/18/10) and John P Leonard, MD (6/28/10)
Pettengell R et al. Randomized study of rituximab in patients with relapsed or resistant follicular lymphoma prior to high-dose therapy as in vivo purging and to maintain remission following high-dose therapy. Proc ASCO 2010;Abstract 8005. |
||||||||